Literature DB >> 8413203

Control of calcitonin/calcitonin gene-related peptide pre-mRNA processing by constitutive intron and exon elements.

J M Yeakley1, F Hedjran, J P Morfin, N Merillat, M G Rosenfeld, R B Emeson.   

Abstract

The calcitonin/calcitonin gene-related peptide (CGRP) primary transcript is alternatively spliced in thyroid C cells and neurons, resulting in the tissue-specific production of calcitonin and CGRP mRNAs. Analyses of mutated calcitonin/CGRP transcription units in permanently transfected cell lines have indicated that alternative splicing is regulated by a differential capacity to utilize the calcitonin-specific splice acceptor. The analysis of an extensive series of mutations suggests that tissue-specific regulation of calcitonin mRNA production does not depend on the presence of a single, unique cis-active element but instead appears to be a consequence of suboptimal constitutive splicing signals. While only those mutations that altered constitutive splicing signals affected splice choices, the action of multiple regulatory sequences cannot be formally excluded. Further, we have identified a 13-nucleotide purine-rich element from a constitutive exon that, when placed in exon 4, entirely switches splice site usage in CGRP-producing cells. These data suggest that specific exon recruitment sequences, in combination with other constitutive elements, serve an important function in exon recognition. These results are consistent with the hypothesis that tissue-specific alternative splicing of the calcitonin/CGRP primary transcript is mediated by cell-specific differences in components of the constitutive splicing machinery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413203      PMCID: PMC364659          DOI: 10.1128/mcb.13.10.5999-6011.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  75 in total

1.  Cooperation of pre-mRNA sequence elements in splice site selection.

Authors:  Z Dominski; R Kole
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

2.  SR proteins: a conserved family of pre-mRNA splicing factors.

Authors:  A M Zahler; W S Lane; J A Stolk; M B Roth
Journal:  Genes Dev       Date:  1992-05       Impact factor: 11.361

3.  Identification of exon sequences and an exon binding protein involved in alternative RNA splicing of calcitonin/CGRP.

Authors:  G J Cote; D T Stolow; S Peleg; S M Berget; R F Gagel
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

Review 4.  Biochemical mechanisms of constitutive and regulated pre-mRNA splicing.

Authors:  M R Green
Journal:  Annu Rev Cell Biol       Date:  1991

5.  Two members of a conserved family of nuclear phosphoproteins are involved in pre-mRNA splicing.

Authors:  A Mayeda; A M Zahler; A R Krainer; M B Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

6.  Nonsense mutations inhibit splicing of MVM RNA in cis when they interrupt the reading frame of either exon of the final spliced product.

Authors:  L K Naeger; R V Schoborg; Q Zhao; G E Tullis; D J Pintel
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

7.  Positive control of pre-mRNA splicing in vitro.

Authors:  M Tian; T Maniatis
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

8.  A novel calcitonin-encoding mRNA is produced by alternative processing of calcitonin/calcitonin gene-related peptide-I pre-mRNA.

Authors:  G J Adema; P D Baas
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

9.  In vitro splicing of cardiac troponin T precursors. Exon mutations disrupt splicing of the upstream intron.

Authors:  T A Cooper
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

10.  Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.

Authors:  A Mayeda; A R Krainer
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

View more
  38 in total

1.  An exonic splicing silencer in the testes-specific DNA ligase III beta exon.

Authors:  S L Chew; L Baginsky; I C Eperon
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Requirements for mini-exon inclusion in potato invertase mRNAs provides evidence for exon-scanning interactions in plants.

Authors:  C G Simpson; P E Hedley; J A Watters; G P Clark; C McQuade; G C Machray; J W Brown
Journal:  RNA       Date:  2000-03       Impact factor: 4.942

3.  Alternative splicing of U12-dependent introns in vivo responds to purine-rich enhancers.

Authors:  R C Dietrich; G C Shukla; J D Fuller; R A Padgett
Journal:  RNA       Date:  2001-10       Impact factor: 4.942

4.  Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.

Authors:  M J Simard; B Chabot
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

Review 5.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

6.  A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.

Authors:  M P Wentz; B E Moore; M W Cloyd; S M Berget; L A Donehower
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  An RNA splicing enhancer-like sequence is a component of a splicing inhibitor element from Rous sarcoma virus.

Authors:  L M McNally; M T McNally
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

8.  A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly.

Authors:  Z M Zheng; M Huynen; C C Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.

Authors:  B A Amendt; D Hesslein; L J Chang; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Selection and characterization of replication-competent revertants of a Rous sarcoma virus src gene oversplicing mutant.

Authors:  L Zhang; S B Simpson; C M Stoltzfus
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.